Accelerate study design and ensure patients receive the right IP. Trust the cloud-based randomization and trial supply solution rated #1 in industry leadership.
Automation, predictive analytics, and remote monitoring enable sponsors to manage critical drug supply chains for complex study protocols.
IQVIA IRT is a randomization and trial supply solution for your site-based or decentralized trial that supports today’s sophisticated trial protocols and ensures the right patient gets the right treatment at the right time:
Reduce time, effort, and cost in drug management by replacing siloed manual processes with the advanced supply and accountability capabilities of IQVIA IRT.
IQVIA scientific and clinical experts understand what it takes to deploy sophisticated trials — from study design to delivery and change management.
We chose IQVIA IRT as a preferred provider for many reasons. The user interface was strong and scored higher than other systems in having a portal that is easy to understand and offered a single enterprise login. [They] offer a robust audit functionality, a clear compliance trail, and a high level of customer service and support.
Associate Director, Information and Systems Strategy,
Leading Pharmaceutical Company
We have received positive feedback from end users and have recognized significant shipment cost savings compared to the previous period before implementation of SAVE. The journey has just started for us. The next step will be to leverage the tool expertise – with IQVIA support – into the entire drug supply manager community and include the tool in new trials.
Vendor Partnership & Governance team,
Leading Pharmaceutical Company
Learn about strategies for mitigating the complexities of Cell and Gene Therapy trials, while reducing risk and cost.
Published on PharmaPhorum by Cara Woodruff, Director of Product Management, IQVIA IRT
Save upwards of $20,000 a month through automated supply optimization
Improve quality and sustainability while reducing cost and risk
Learn more about how IRT improves quality and efficiencies in medical device trials
Published on Technology Networks Drug Discovery
By Maxime Schuchewytsch, Associate Director of Product Management, Cenduit IRT, an IQVIA Business
Deliver eConsent to sites and study participants around the globe with confidence
Improve study quality, accelerate decision making and reduce site and sponsor burden by harnessing the power of IQVIA’s integrated Interactive Response Technology (IRT) and electronic Clinical Outcome Assessment (eCOA) solution.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
.svg){kind=icon}
